Obstructive hypertrophic cardiomyopathy, oHCM, is a rare heart condition with serious consequences, but most people suffer with one misdiagnosis after another, and no effective treatments to help them even if diagnosed. Patients spend years going nowhere…feeling confused, frustrated, lost.

We needed to highlight this issue in a new way and raise awareness and urgency in the medical community. The “Stranded” unbranded campaign is emblematic of the patient journey and dramatizes the unmet need for diagnosing and treating oHCM. Change has been long overdue.

For years, patients with a rare bone cancer, myelofibrosis, have faced a dead end. So, when Inrebic, the first new therapy in a decade came to market, we not only wanted to make HCPs aware of this new option but also truly experience the relentless symptoms that were causing their patients to suffer. The unbearable night sweats, the non-stop fatigue, and the overwhelming burden of an enlarged spleen.

“The See What They Feel” campaign brought patients’ symptoms to life in surprising, dramatic ways, making it nearly impossible to ignore the problem any longer.

Cardiologists have only been able to manage the symptoms of a serious cardiac condition, obstructive hypertrophic cardiomyopathy (oHCM), instead of treating the underlying cause of the disease. For the very first time in oHCM history, there is finally a treatment that targets the disease at the source, with significant clinical results. And physicians are all about results.

The “Power of Numbers” campaign is striking and memorable. It highlights the data in an unexpected way and draws the audience in to learn more about this first-in-class oHCM treatment.

As part of a new business pitch for Solosec, we were charged with creating a campaign that changes the way patients with bacterial vaginosis (BV) think about their condition. Women have been inconvenienced and uncomfortable with medications that take either multiple days to work or come in the form of messy gels or creams.

“Redefine BV” and “BV Packet Up!” are two powerful patient campaigns that communicate the control women can finally have over their condition with a simple, no-nonsense one-dose treatment.

Onureg is the first and only continued treatment for acute myeloid leukemia (AML) and launched in the US in September 2020.

“The Eclipse Campaign” debuted at launch and highlighted this unique treatment for AML by featuring a phenomenon that was pretty unique itself—an eclipse.

The biggest issue with chronic obstructive pulmonary disease (COPD) inhalers is that patients often use them incorrectly. How can they get the results they need if all of the medication isn’t being delivered?

The “Delivery Counts” campaign was an unbranded campaign to raise awareness of the shortcomings of current COPD hand-held devices. This created an unmet need that Lonhala Magnair, a new and effective nebulizing device that was coming to market, could later fill.

Sick cell disease is a 365-days-a-year condition. Every day is unpredictable. Every day is a sick day. Finally with a convenient, once daily treatment for sick cell disease, we can change the meaning of sick for patients.

The “Sick Day” campaign communicates that a day feeling fatigued and suffering from shortness of breath can now turn into a day of feeling good.

Peanut allergies leave kids feeling scared and out of control. The power is in the hands of the peanut instead of them. But with a new treatment that slowly introduces the peanut allergen into the body over time, kids are in training to overcome their allergy.

The “Hey Peanut” campaign empowers kids to take back their power from the peanut and finally get their allergy under control.

“The Vines” was a global unbranded campaign that helped create urgency and awareness about myelofibrosis progression and that worsening symptoms may be creeping up on patients more than HCPs think. This pre-launch disease awareness campaign helped set up the need for Inrebic, the first myelofibrosis treatment in a decade, which launched globally in 2021.

The chronic obstructive pulmonary disease (COPD) marketplace is an extremely crowded space so when a new device comes along, it needs to stand out. And with a unique one-of-a-kind nebulizer like Lonhala Magnair, we needed HCPs to see how it could transform a patient’s day.

By literally constructing a home on the convention floor, “Room to Breathe” allowed HCPs to take a guided tour of a patient’s home and experience the unique features of this device firsthand. Each room of the home dramatized a feature of Lonhala Magnair…virtually silent, quick, portable. It was an immersive experience like nothing physicians had ever been a part of.

What do you do when a product isn’t fully available to the market, but you still want physicians to experience it for themselves? You find another way to put the product in physicians’ hands.

“The Magnair Experience” used augmented reality to bring each of the unique features of a new nebulizer, Lonhala Magnair, to life so that HCPs felt like they were engaging with it firsthand. This unique initiative helped to successfully create anticipation and excitement in the COPD market and drive demand for Lonhala Magnair before it was even available to physicians.

For the first time in cardiovascular history, there’s a first-in-class treatment that targets a rare heart condition, oHCM, where it needs it most—at the source. The “Celebration” branded campaign brings this momentous occasion to life and captures the excitement and groundbreaking impact for the cardiovascular community. Finally, CAMZYOS is shining a spotlight on this serious disease and giving oHCM the attention it deserves.

The photographic style portrays three unique visual executions. Each visual captures the same feelings of bigness and excitement but features a different celebratory venue—an opening ceremony, a rock concert, and an award show—with the heart as the main event. Use of similar lighting, colors, crowded audience, and the same captivating heart connect the three venues together as one momentous celebratory campaign.

Chronic obstructive pulmonary disease (COPD) impacts patients’ lives at every moment of every day, so in order for a new treatment to be successful, it needs do the same.

“Magnair Moments” were mini commercial-like videos that brought three unique features of Lonhala Magnair to life in surprising, dramatic ways so that physicians could see its impact on patients’ every day. See what virtually silent, 2-3-minute administration, and portability can mean for a patient.

How do HCPs know what patients really think and feel when suffering with a disease or if their medication is working? Are they holding back, afraid to share what’s truly going on? We decided to find out.

Similar to Chevrolet’s Real people, Not actors campaign, “Behind the Glass” let real patients with COPD experience Lonhala Magnair for themselves, truly capturing what they think and feel about this new nebulizer. It gave HCPs the opportunity to hear patients’ feedback firsthand while patients in turn, felt comfortable to speak candidly due to the protection of a one-way mirror. It was a powerful and emotional initiative behind and in front of the glass.